Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

6.89

-0.01 (-0.14%)

At close: Apr 6, 2026, 4:00 PM EDT

7.03

+0.14 (2.03%)

After-hours: Apr 6, 2026, 5:54 PM EDT

Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	228.37	230.47	235.64	228.03	253.16
Revenue Growth (YoY)	-0.91%	-2.19%	3.34%	-9.92%	12.46%
Cost of Revenue	58.16	64.4	62.68	55.09	63.7
Gross Profit	170.21	166.06	172.96	172.94	189.45
Selling, General & Admin	70.85	80.16	89.93	89.98	116.29
Research & Development	62.07	54.94	50.38	52.24	71.87
Other Operating Expenses	-	-	-	7	-
Total Operating Expenses	132.92	135.1	140.32	149.22	188.16
Operating Income	37.3	30.97	32.64	23.72	1.29
Interest Income	4.08	4.72	2.61	0.81	0.16
Interest Expense	-6.62	-12.45	-13.33	-11.59	-12.81
Other Non-Operating Income (Expense)	1.03	0.86	0.76	-12.48	-17.45
Total Non-Operating Income (Expense)	-1.52	-6.87	-9.97	-23.26	-30.09
Pretax Income	35.78	24.1	22.67	0.46	-28.8
Provision for Income Taxes	4.67	-6.18	1.08	0.46	0.32
Net Income	31.11	30.28	21.59	0	-29.13
Net Income to Common	31.11	30.28	21.59	0	-29.13
Net Income Growth	2.75%	40.23%	1079450.00%	-	-
Shares Outstanding (Basic)	50	49	47	45	41
Shares Outstanding (Diluted)	51	49	48	45	41
Shares Change (YoY)	3.16%	3.26%	5.83%	10.56%	2.69%
EPS (Basic)	0.62	0.62	0.46	-	-0.72
EPS (Diluted)	0.61	0.62	0.45	-	-0.72
EPS Growth	-1.61%	37.78%	-	-	-
Shares Outstanding	50.41	49.11	47.65	46.35	41.18
Free Cash Flow	41.73	38.86	26.87	-15.83	20.65
Free Cash Flow Growth	7.38%	44.64%	-	-	2740.44%
Free Cash Flow Per Share	0.82	0.79	0.57	-0.35	0.51
Gross Margin	74.53%	72.06%	73.40%	75.84%	74.84%
Operating Margin	16.33%	13.44%	13.85%	10.40%	0.51%
Profit Margin	13.62%	13.14%	9.16%	0.00%	-11.51%
FCF Margin	18.27%	16.86%	11.40%	-6.94%	8.16%
EBITDA	48.24	42.49	44.16	33.56	12.6
EBITDA Margin	21.12%	18.44%	18.74%	14.72%	4.98%
EBIT	37.3	30.97	32.64	23.72	1.29
EBIT Margin	16.33%	13.44%	13.85%	10.40%	0.51%
Effective Tax Rate	13.05%	-25.63%	4.78%	99.56%	-1.12%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q